Rita Ötvös

Publications
Public outreach and news

Articles

Article: BMC CANCER. 2011;11:441

Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.

Otvös R; Skribek H; Kis LL; Gloghini A; Markasz L; Flaberg E; Eksborg S; Konya J; Gergely L; Carbone A; Szekely L
Article: EXPERIMENTAL HEMATOLOGY. 2010;38(12):1219-1230

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.

Skribek H; Otvos R; Flaberg E; Nagy N; Markasz L; Eksborg S; Masszi T; Kozma A; Adam E; Miseta A; Klein E; Szekely L
Article: BIOMEDICINE & PHARMACOTHERAPY. 2009;63(6):413-420

NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab.

Markasz L; Vanherberghen B; Flaberg E; Otvös R; Stuber G; Gustafsson Jernberg A; Olah E; Skribek H; Szekely L
Article: MOLECULAR CANCER. 2009;8:23

PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.

Stuber G; Flaberg E; Petranyi G; Otvös R; Rökaeus N; Kashuba E; Wiman KG; Klein G; Szekely L
Article: JOURNAL OF IMMUNOTHERAPY. 2008;31(3):283-293

Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.

Markasz L; Skribek H; Uhlin M; Otvos R; Flaberg E; Eksborg S; Olah E; Stuber G; Szekely L
Article: LEUKEMIA & LYMPHOMA. 2007;48(9):1835-1845

Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel.

Markasz L; Kis LL; Stuber G; Flaberg E; Otvos R; Eksborg S; Skribek H; Olah E; Szekely L

Articles

News from KI

Events from KI